BIODESIX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
BIODESIX, INC. (BDSX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 14.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-05
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 10.00K shares, a 91.15% decline year-over-year.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 4.00K shares, a 94.59% decline year-over-year.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 5.00K shares, a 86.84% decline year-over-year.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was -163.00K shares, a 283.15% decline year-over-year.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 29.00K shares, a 88.80% decline from fiscal 2024.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 259.00K shares, a 29.04% decline from fiscal 2023.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 365.00K shares, a 9.61% increase from fiscal 2022.
- BIODESIX, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 333.00K shares, a 147900.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 10.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 14.00K shares 10-Q · filed 2026-08-05 | 19.00K shares derived: sum of 3 quarters · filed 2026-08-05 | -144.00K shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 4.00K shares 10-Q · filed 2026-05-04 | 9.00K shares derived: sum of 2 quarters · filed 2026-05-04 | -154.00K shares derived: sum of 3 quarters · filed 2026-05-04 | -41.00K shares derived: sum of 4 quarters · filed 2026-05-04 |
| 2025-12-31 | 5.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -158.00K shares derived: sum of 2 quarters · filed 2026-02-26 | -45.00K shares derived: sum of 3 quarters · filed 2026-02-26 | 29.00K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | -163.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -50.00K shares derived: sum of 2 quarters · filed 2025-11-03 | 24.00K shares 10-Q · filed 2025-11-03 | 62.00K shares derived: sum of 4 quarters · filed 2025-11-03 |
| 2025-06-30 | 113.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 187.00K shares 10-Q · filed 2025-08-07 | 225.00K shares derived: sum of 3 quarters · filed 2025-08-07 | 314.00K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 74.00K shares 10-Q · filed 2025-05-13 | 112.00K shares derived: sum of 2 quarters · filed 2025-05-13 | 201.00K shares derived: sum of 3 quarters · filed 2025-05-13 | 271.00K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 38.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 127.00K shares derived: sum of 2 quarters · filed 2025-03-03 | 197.00K shares derived: sum of 3 quarters · filed 2025-03-03 | 259.00K shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 89.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | 159.00K shares derived: sum of 2 quarters · filed 2024-11-01 | 221.00K shares 10-Q · filed 2024-11-01 | 273.00K shares derived: sum of 4 quarters · filed 2024-11-01 |
| 2024-06-30 | 70.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 132.00K shares 10-Q · filed 2024-08-07 | 184.00K shares derived: sum of 3 quarters · filed 2024-08-07 | 261.00K shares derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-31 | 62.00K shares 10-Q · filed 2024-05-08 | 114.00K shares derived: sum of 2 quarters · filed 2024-05-08 | 191.00K shares derived: sum of 3 quarters · filed 2024-05-08 | 355.00K shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 52.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | 129.00K shares derived: sum of 2 quarters · filed 2024-03-01 | 293.00K shares derived: sum of 3 quarters · filed 2024-03-01 | 365.00K shares 10-K · filed 2024-03-01 |
| 2023-09-30 | 77.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 241.00K shares derived: sum of 2 quarters · filed 2023-11-07 | 313.00K shares 10-Q · filed 2023-11-07 | 377.00K shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 164.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 236.00K shares 10-Q · filed 2023-08-07 | 300.00K shares derived: sum of 3 quarters · filed 2023-08-07 | 415.00K shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 72.00K shares 10-Q · filed 2023-05-11 | 136.00K shares derived: sum of 2 quarters · filed 2023-05-11 | 251.00K shares derived: sum of 3 quarters · filed 2023-05-11 | 335.00K shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 64.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 179.00K shares derived: sum of 2 quarters · filed 2023-03-06 | 263.00K shares derived: sum of 3 quarters · filed 2023-03-06 | 333.00K shares 10-K · filed 2023-03-06 |
| 2022-09-30 | 115.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 199.00K shares derived: sum of 2 quarters · filed 2022-11-03 | 269.00K shares 10-Q · filed 2022-11-03 | 106.22K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 84.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 154.00K shares 10-Q · filed 2022-08-04 | -8.78K shares derived: sum of 3 quarters · filed 2022-08-04 | 32.23K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 70.00K shares 10-Q · filed 2022-05-11 | -92.78K shares derived: sum of 2 quarters · filed 2022-05-11 | -51.77K shares derived: sum of 3 quarters · filed 2022-05-11 | 8.22K shares derived: sum of 4 quarters · filed 2022-05-11 |
| 2021-12-31 | -162.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | -121.78K shares derived: sum of 2 quarters · filed 2022-03-14 | -61.77K shares derived: sum of 3 quarters · filed 2022-03-14 | 225.00 shares 10-K · filed 2022-03-14 |
| 2021-09-30 | 41.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 101.00K shares derived: sum of 2 quarters · filed 2021-11-15 | 163.00K shares 10-Q · filed 2021-11-15 | 178.00K shares derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | 60.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | 122.00K shares 10-Q · filed 2021-08-10 | 137.00K shares derived: sum of 3 quarters · filed 2021-08-10 | |
| 2021-03-31 | 62.00K shares 10-Q · filed 2021-05-11 | 77.00K shares derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2020-12-31 | 15.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 55.00K shares 10-K · filed 2021-03-16 | ||
| 2020-09-30 | 40.00K shares 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |